Fundraising Fox
Kendall Capital Partners
Venture capitalBoston · Seed–Growth · 7 people tracked
Also known as Kendall
Find your way into Kendall Capital Partners
Each arrow is one introduction. Sign up to fill in the first one.
Ask Hunter Kellett to introduce you to Neil Butler
You →Hunter · together at Arnold Ventures →Neil
Ask Jamie Chen to introduce you to David Zhu
You →Jamie · together at KeyBanc Capital Markets →David
Ask Sam Okafor to introduce you to Robert Langer
You →Sam · together at Lyndra →Robert
- Richard Bendis44 people can intro you
- Jennifer Butler26 people can intro you
- Dwip Ratan Mahajan9 people can intro you
Sign up to find every way you can get introduced to Kendall Capital Partners
- Your email: who you already know at Kendall Capital Partners, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Kendall Capital Partners team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Kendall Capital Partners invests in transformative life sciences and healthcare innovations addressing urgent global medical needs. The firm focuses on breakthrough science in gene and cell therapies, precision immunotherapies, advanced drug delivery systems, and AI-powered diagnostic and manufacturing platforms. Investment decisions are informed by a world-class scientific advisory board and partnerships with elite research institutions including MIT, Harvard, and Columbia. The firm seeks to de-risk innovations through rigorous scientific and operational diligence, build enduring companies, and deliver measurable health impact alongside financial returns for institutional investors, family offices, and high-net-worth individuals.
Source: firm website, verified Aug 6, 2026.
Team · 7 people
from the firm's website & curated
Founder mafia
2 people who came through Kendall Capital Partners went on to found or lead other companies.
What they invest in
from 14 of 14 portfolio companiesBiotech ×10Healthtech ×6Medical Devices ×3Hardware ×2AI & Machine Learning ×1Deep Tech ×1Defense Tech ×1Digital Health ×1
HQs:United States×12United Kingdom×1
Investments · 14 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12023 · 22022 · 12019 · 22017 · 12016 · 32015 · 112 dated
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
Board seatGeorge M. Church· per SEC Form D · $3M raise · filed Aug 2016
Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPHBM Healthcare InvestmentsHBM PartnersKhosla Ventures+13 more
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.
BiotechHealthtechMedical DevicesNew York, US
Nina Tandon(Co-Founder, CEO)inSarindr Bhumiratana(Co-Founder)inGordana Vunjak-Novakovic(Director)Elma Hawkins(Director)
Board seatRobert Langer· per SEC Form D
Co-investorsBeresford VenturesEMV CapitalHackensack Meridian Health Bear's DenLifespan Vision VenturesMEDA AngelsPlum Alley Investments+2 more
BiotechCambridge, US
Torben Straight Nissen(Executive Officer, Director)inJoanne Protano(Executive Officer)inDavid Epstein(Director)Harvey F. Lodish(Director)Michael Rosenblatt(Director)Roger Pomerantz(Director)in
Board seatRobert Langer· per SEC Form D · $120M raise · filed Jun 2017
Co-investorsFlagship PioneeringFlagship Ventures
BiotechWatertown, US
Omid Farokhzad(Director)inRobert S. Langer, Jr.(Director)Omid C. Farokhzad(Director)inRobert S. Langer(Director)Andrew J. Fromkin(Executive Officer, Director)Leila Alland(Executive Officer)in
Board seatRobert Langer· per SEC Form D · $38M raise · filed Feb 2017
Co-investors+ND CapitalNew Enterprise Associates (NEA)
Blu Wireless develops millimeter wave radio networking technology for wireless communications.
Deep TechDefense TechHardwareSemiconductorsBristol, GB
Anthony Murray(Chief Executive Officer)inJohnny Bray(Chief Financial Officer)inDave Purle(Chief Operating Officer)Ciara Barron(Director of Marketing)inDarren McNamara(Director of Technology Development)inJonathan Rogers(Director of Systems and Platforms)in
Co-investorsMaven Capital PartnersCambridge Angels groupPerscitus LLPSalica InvestmentsARMCalculus Capital Ltd.+1 more
Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.
BiotechHealthtech
Jacob Glanville(Founder)inStephanie Wisner(Founder)in
Co-investorsAmplify PartnersBold Capital PartnersFuture VenturesGlobal Health Investment CorporationNFX
Eyenuk provides autonomous AI-based eye exams performed at the point of care to detect eye conditions including diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous signs.
AI & Machine LearningDigital HealthHealthtechMedical DevicesWoodland Hills, US
Kaushal Solanki(Founder; Director, PhD)inGaurav Agarwal(Chief Executive Officer)in
BoardMads Dall(Director)Zina Affas Besse(Director)Marie-Louise Little(Director)
General Fluidics builds Axess, a point-of-care diagnostic analyzer powered by its patented Embedded Fluidics Systems that runs clinical chemistry, hematology, and immunoassay panels from a single cartridge in under 20 minutes.
HardwareHealthtechMedical DevicesWaltham, US
Robert Granier(Executive Officer, Director)inRobert Warren(Executive Officer)inJason Napolitano(Director)Ronald Tompkins(Director)
BoardMarc Goldberg(Director)Timothy Hirsch(Director)
Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(CSO, Co-Founder)inDaniel Oliver(CEO, Co-Founder)inGeorge Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)in
Co-investorsCompanion FundConnecticut InnovationsDigitalis VenturesLifespan Vision VenturesVCapitalKdT Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Bilayer TherapeuticsFrequency TherapeuticsLyndraMicrochips BiotechOmniPulse Biosciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companies
Eyenuk · intelligence360.news · Jul 20, 2026
Rejuvenate Bio · finsmes.com · Jun 8, 2026
Centivax · finsmes.com · Mar 30, 2026
Frequently asked questions
- How many investments has Kendall Capital Partners made?
- Kendall Capital Partners has 14 tracked investments, including 2 dated in the last 24 months.
- What stage does Kendall Capital Partners invest at?
- Kendall Capital Partners invests at the Seed, Series A, Series B, Growth stages.
- What sectors does Kendall Capital Partners focus on?
- Kendall Capital Partners focuses on AI & Machine Learning, Biotech, Digital Health, Medical Devices.
- Where is Kendall Capital Partners located?
- Kendall Capital Partners is headquartered in Boston, US.
- Who does Kendall Capital Partners co-invest with?
- Kendall Capital Partners most often shares deals with Lifespan Vision Ventures, Amplify Partners, Bold Capital Partners, among 17 tracked co-investors.
Similar investors
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.
Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
Marram Ventures is a healthcare-focused venture capital firm that invests in companies connecting whole-person health to long-term outcomes across convergent care delivery, diagnostics, and connective healthcare infrastructure.